{
    "2018-11-05": [
        [
            {
                "time": "",
                "original_text": "智飞生物：与美国默沙东公司签署HPV疫苗相关协议",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "默沙东",
                        "HPV疫苗",
                        "协议"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：与默沙东签新约，HPV疫苗基础采购计划达180亿元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "默沙东",
                        "HPV疫苗",
                        "采购计划",
                        "180亿元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物与默沙东签新约 HPV疫苗基础采购计划达180亿元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "默沙东",
                        "HPV疫苗",
                        "采购计划",
                        "180亿元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2018年三季报总结:医药分化加剧,把握产业龙头",
                "features": {
                    "keywords": [
                        "医药行业",
                        "三季报",
                        "分化加剧",
                        "产业龙头"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}